One thing is clear now that it has taken this long to review. NICE is not going to approve. No wonder NWBO has not submitted evidence 5+ years since data lock. All kinds of excuses around 10 year survival data to Flaskworks/Eden will be thrown by minions for not submitting evidence. You can bet there will be no approval from NICE in 2026. Unlikely in 2027 either.
Another thing is that they don’t plan on applying to FDA with the phase 3 data. Otherwise, no serious company would wait 5+ years to submit a BLA to the biggest and most lucrative market (almost 20X of the tiny UK). They obviously didn’t disclose this to shareholders, which is typical NWBO! ;)
Finally, all time lows are coming in 2026 after the additional 900M shares are authorized. It’s going to be a race to the bottom. LP’s financiers and shorts will have an extended party. Easy money!
Market Data 
Markets 
AI
